#moderna merck cancer vaccine

Moderna and Merck are collaborating on an mRNA-based cancer vaccine, which is being developed to enhance the immune response against certain types of cancer, with promising results in clinical trials for melanoma. The vaccine aims to train the immune system to recognize and attack cancer cells more effectively when used in combination with Merck's immunotherapy drug, Keytruda.